Several other TREM2 variants associated with AD and frontotemporal dementia (FTD) have also been found to confer partial loss-of-function, as they impair TREM2 binding to ligands, maturation, ectodomain shedding and microglial phagocytic activity [33]. The gene discussed is TREM2; the disease is Alzheimer disease.